{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T08:06:03Z","timestamp":1775289963626,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virus Genes"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11262-026-02214-1","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:47:35Z","timestamp":1770061655000},"page":"167-176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["VP1 molecular evolution of type 2 immunodeficiency-related vaccine-derived polioviruses (iVDPV2) in a patient with primary immunodeficiency disease (PID)"],"prefix":"10.1007","volume":"62","author":[{"given":"Ahmad","family":"Nejati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshad","family":"Khodakhah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parastoo","family":"Soheili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaghoob","family":"Mollaei-Kandelous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Keyvanlou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Razaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delaram","family":"Yaghoubzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohsen","family":"Zahraei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sussan","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohreh","family":"Shahmahmoodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"issue":"10","key":"2214_CR1","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1099\/jgv.0.000911","volume":"98","author":"R Zell","year":"2017","unstructured":"Zell R, Delwart E, Gorbalenya A, Hovi T, King A, Knowles N et al (2017) ICTV virus taxonomy profile: Picornaviridae. J Gen Virol 98(10):2421\u20132422","journal-title":"J Gen Virol"},{"key":"2214_CR2","unstructured":"Zhu L (2017) Structural and functional study of picornaviruses: University of Oxford."},{"issue":"1","key":"2214_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50921-w","volume":"15","author":"Z Zhong","year":"2024","unstructured":"Zhong Z, Su X, Yang K, Huang W, Wang J, Zhuo Z et al (2024) Sequence-specific nanoparticle barcode strategy for multiplex human enterovirus typing. Nat Commun 15(1):6478","journal-title":"Nat Commun"},{"key":"2214_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02339","volume":"9","author":"M-L Joffret","year":"2018","unstructured":"Joffret M-L, Polston PM, Razafindratsimandresy R, Bessaud M, Heraud J-M, Delpeyroux F (2018) Whole genome sequencing of enteroviruses species A to D by high-throughput sequencing: application for viral mixtures. Front Microbiol 9:2339","journal-title":"Front Microbiol"},{"issue":"10432","key":"2214_CR5","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/S0140-6736(23)02844-1","volume":"403","author":"M Ochoge","year":"2024","unstructured":"Ochoge M, Futa AC, Umesi A, Affleck L, Kotei L, Daffeh B et al (2024) Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to< 5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial. The Lancet 403(10432):1164\u20131175","journal-title":"The Lancet"},{"issue":"5","key":"2214_CR6","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.chom.2020.04.003","volume":"27","author":"M Te Yeh","year":"2020","unstructured":"Te Yeh M, Bujaki E, Dolan PT, Smith M, Wahid R, Konz J et al (2020) Engineering the live-attenuated polio vaccine to prevent reversion to virulence. Cell host microbe 27(5):736\u2013751","journal-title":"Cell host microbe"},{"key":"2214_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-71165-8_30","author":"AS Bandyopadhyay","year":"2021","unstructured":"Bandyopadhyay AS, Macklin GR (2021) Global polio eradication: progress and challenges. Human Viruses: Dis, Treat Vaccines: New Insights. https:\/\/doi.org\/10.1007\/978-3-030-71165-8_30","journal-title":"Human Viruses: Dis, Treat Vaccines: New Insights"},{"key":"2214_CR8","doi-asserted-by":"publisher","first-page":"36867","DOI":"10.5812\/archcid.36867","volume":"11","author":"SM Razavi","year":"2016","unstructured":"Razavi SM, Mardani M, Salamati P (2016) Eradication of polio in the world; Iran is at risk for reemerging of polio: a review of the literature. Arch Clin Infect Dis 11:36867","journal-title":"Arch Clin Infect Dis"},{"issue":"1","key":"2214_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","volume":"59","author":"OM Kew","year":"2005","unstructured":"Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA (2005) Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59(1):587\u2013635","journal-title":"Annu Rev Microbiol"},{"key":"2214_CR10","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7341a1","author":"A Namageyo-Funa","year":"2024","unstructured":"Namageyo-Funa A (2024) Update on vaccine-derived poliovirus outbreaks\u2014worldwide, January 2023\u2013June 2024. MMWR Morb Mortal Wkly Rep. https:\/\/doi.org\/10.15585\/mmwr.mm7341a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2214_CR11","doi-asserted-by":"publisher","first-page":"S283","DOI":"10.1093\/infdis\/jiu295","volume":"210","author":"CC Burns","year":"2014","unstructured":"Burns CC, Diop OM, Sutter RW, Kew OM (2014) Vaccine-derived polioviruses. J Infect Dis 210(1):S283\u2013S293","journal-title":"J Infect Dis"},{"issue":"11","key":"2214_CR12","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3201\/eid2511.190540","volume":"25","author":"M Shaghaghi","year":"2019","unstructured":"Shaghaghi M, Shahmahmoodi S, Nili A, Abolhassani H, Madani SP, Nejati A et al (2019) Vaccine-derived poliovirus infection among patients with primary immunodeficiency and effect of patient screening on disease outcomes. Iran Emerg Infect Dis 25(11):2005","journal-title":"Iran Emerg Infect Dis"},{"issue":"30","key":"2214_CR13","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1016\/j.vaccine.2014.05.022","volume":"32","author":"N Principi","year":"2014","unstructured":"Principi N, Esposito S (2014) Vaccine use in primary immunodeficiency disorders. Vaccine 32(30):3725\u20133731","journal-title":"Vaccine"},{"issue":"7","key":"2214_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/v13071407","volume":"13","author":"K Kitamura","year":"2021","unstructured":"Kitamura K, Shimizu H (2021) The molecular evolution of type 2 vaccine-derived polioviruses in individuals with primary immunodeficiency diseases. Viruses 13(7):1407","journal-title":"Viruses"},{"key":"2214_CR15","doi-asserted-by":"publisher","DOI":"10.1017\/S095026881900181X","volume":"147","author":"D Kalkowska","year":"2019","unstructured":"Kalkowska D, Pallansch M, Thompson K (2019) Updated modelling of the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus (iVDPV) excreters. Epidemiol Infect 147:e295","journal-title":"Epidemiol Infect"},{"issue":"4","key":"2214_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4172\/2157-7560.1000331","volume":"7","author":"Z El-Sayed","year":"2016","unstructured":"El-Sayed Z, Mach O, Hossny E, Galal N, El-Sawy I, Elmarsafy A et al (2016) Poliovirus excretion among persons with primary immune deficiency disorders: summary of data from enhanced poliovirus surveillance in Egypt, 2011\u20132014. J Vaccines Vaccin 7(4):331\u2013336","journal-title":"J Vaccines Vaccin"},{"key":"2214_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01103","volume":"8","author":"G Macklin","year":"2017","unstructured":"Macklin G, Liao Y, Takane M, Dooling K, Gilmour S, Mach O et al (2017) Prolonged excretion of poliovirus among individuals with primary immunodeficiency disorder: an analysis of the World Health Organization registry. Front Immunol 8:1103","journal-title":"Front Immunol"},{"issue":"1","key":"2214_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-024-09731-0","volume":"24","author":"MR Shabana","year":"2024","unstructured":"Shabana MR, Zaghloul AY, El Shaarawy TH, Elleboudy NS, Aboshanab KM (2024) Monitoring the VDPV2 outbreak in Egypt during 2020\u20132021 highlights the crucial role of environmental surveillance and boosting immunization in combating Poliovirus. BMC Infect Dis 24(1):1\u201315","journal-title":"BMC Infect Dis"},{"key":"2214_CR19","unstructured":"Persons I, County W, Virginia W (2020) Update on Vaccine-Derived Poliovirus Outbreaks Worldwide, July 2019-February 2020. Notes."},{"issue":"1-2","key":"2214_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jviromet.2011.03.020","volume":"174","author":"DR Kilpatrick","year":"2011","unstructured":"Kilpatrick DR, Iber JC, Chen Q, Ching K, Yang S-J, De L et al (2011) Poliovirus serotype-specific VP1 sequencing primers. J Virol Methods 174(1\u20132):128\u2013130","journal-title":"J Virol Methods"},{"issue":"1","key":"2214_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00355-y","volume":"6","author":"R Wahid","year":"2021","unstructured":"Wahid R, Mercer L, Macadam A, Carlyle S, Stephens L, Martin J et al (2021) Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses. NPJ Vaccines 6(1):94","journal-title":"NPJ Vaccines"},{"issue":"8","key":"2214_CR22","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1128\/AAC.00878-15","volume":"59","author":"L Schotte","year":"2015","unstructured":"Schotte L, Thys B, Strauss M, Filman DJ, Rombaut B, Hogle JM (2015) Characterization of poliovirus neutralization escape mutants of single-domain antibody fragments (VHHs). Antimicrob Agents Chemother 59(8):4695\u20134706","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"2214_CR23","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1128\/JVI.02354-07","volume":"82","author":"J Jorba","year":"2008","unstructured":"Jorba J, Campagnoli R, De L, Kew O (2008) Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J Virol 82(9):4429\u20134440","journal-title":"J Virol"},{"issue":"9","key":"2214_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/v13091882","volume":"13","author":"E Domingo","year":"2021","unstructured":"Domingo E, Garc\u00eda-Crespo C, Lobo-Vega R, Perales C (2021) Mutation rates, mutation frequencies, and proofreading-repair activities in RNA virus genetics. Viruses 13(9):1882","journal-title":"Viruses"},{"issue":"9","key":"2214_CR25","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1073\/pnas.90.9.4171","volume":"90","author":"JW Drake","year":"1993","unstructured":"Drake JW (1993) Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci U S A 90(9):4171\u20134175","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2214_CR26","doi-asserted-by":"publisher","first-page":"7289","DOI":"10.1073\/pnas.1232294100","volume":"100","author":"JK Pfeiffer","year":"2003","unstructured":"Pfeiffer JK, Kirkegaard K (2003) A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc Natl Acad Sci U S A 100(12):7289\u20137294","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2214_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.virusres.2004.11.007","volume":"107","author":"M Vignuzzi","year":"2005","unstructured":"Vignuzzi M, Stone JK, Andino R (2005) Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications. Virus Res 107(2):173\u2013181","journal-title":"Virus Res"},{"issue":"2","key":"2214_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11262-005-0055-3","volume":"33","author":"E Dedepsidis","year":"2006","unstructured":"Dedepsidis E, Karakasiliotis I, Paximadi E, Kyriakopoulou Z, Komiotis D, Markoulatos P (2006) Detection of unusual mutation within the VP1 region of different re-isolates of poliovirus Sabin vaccine. Virus Genes 33(2):183\u2013191","journal-title":"Virus Genes"},{"key":"2214_CR29","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01949-17","author":"J Shaw","year":"2018","unstructured":"Shaw J, Jorba J, Zhao K, Iber J, Chen Q, Adu F et al (2018) Dynamics of evolution of poliovirus neutralizing antigenic sites and other capsid functional domains during a large and prolonged outbreak. J Virol. https:\/\/doi.org\/10.1128\/jvi.01949-17","journal-title":"J Virol"},{"issue":"13","key":"2214_CR30","doi-asserted-by":"publisher","first-page":"6791","DOI":"10.1128\/JVI.76.13.6791-6799.2002","volume":"76","author":"EA Cherkasova","year":"2002","unstructured":"Cherkasova EA, Korotkova EA, Yakovenko ML, Ivanova OE, Eremeeva TP, Chumakov KM et al (2002) Long-term circulation of vaccine-derived poliovirus that causes paralytic disease. J Virol 76(13):6791\u20136799","journal-title":"J Virol"},{"issue":"13","key":"2214_CR31","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMc1508104","volume":"374","author":"A Schubert","year":"2016","unstructured":"Schubert A, B\u00f6ttcher S, Eis-H\u00fcbinger AM (2016) Two cases of vaccine-derived poliovirus infection in an oncology ward. N Engl J Med 374(13):1296\u20131298","journal-title":"N Engl J Med"},{"issue":"1","key":"2214_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.virusres.2007.03.009","volume":"127","author":"F Adu","year":"2007","unstructured":"Adu F, Iber J, Bukbuk D, Gumede N, Yang S-J, Jorba J et al (2007) Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child. Virus Res 127(1):17\u201325","journal-title":"Virus Res"},{"issue":"5","key":"2214_CR33","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1099\/vir.0.18974-0","volume":"84","author":"G Buttinelli","year":"2003","unstructured":"Buttinelli G, Donati V, Fiore S, Marturano J, Plebani A, Balestri P et al (2003) Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis. J Gen Virol 84(5):1215\u20131221","journal-title":"J Gen Virol"},{"key":"2214_CR34","first-page":"391","volume":"5","author":"E Domingo","year":"2007","unstructured":"Domingo E (2007) Virus Evolution 12. Virus Evol Fields Virol 5:391\u2013422","journal-title":"Virus Evol Fields Virol"},{"key":"2214_CR35","unstructured":"Nguyen T (2018) Ultra-deep sequencing applications in virology research: Sorbonne Universit\u00e9."},{"issue":"24","key":"2214_CR36","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1056\/NEJMoa1008677","volume":"364","author":"AS DeVries","year":"2011","unstructured":"DeVries AS, Harper J, Murray A, Lexau C, Bahta L, Christensen J et al (2011) Vaccine-derived poliomyelitis 12 years after infection in Minnesota. N Engl J Med 364(24):2316\u20132323","journal-title":"N Engl J Med"},{"issue":"7","key":"2214_CR37","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1128\/JVI.02122-08","volume":"83","author":"ML Yakovenko","year":"2009","unstructured":"Yakovenko ML, Korotkova EA, Ivanova OE, Eremeeva TP, Samoilovich E, Uhova I et al (2009) Evolution of the Sabin vaccine into pathogenic derivatives without appreciable changes in antigenic properties: need for improvement of current poliovirus surveillance. J Virol 83(7):3402\u20133406","journal-title":"J Virol"},{"issue":"9","key":"2214_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29918","volume":"96","author":"I Ben Salem","year":"2024","unstructured":"Ben Salem I, Khemiri H, Drechsel O, Arbi M, B\u00f6ttcher S, Mekki N et al (2024) Reversion of neurovirulent mutations, recombination and high intra\u2010host diversity in vaccine\u2010derived poliovirus excreted by patients with primary immune deficiency. J Med Virol 96(9):e29918","journal-title":"J Med Virol"},{"issue":"11","key":"2214_CR39","doi-asserted-by":"publisher","first-page":"7507","DOI":"10.1128\/jvi.68.11.7507-7515.1994","volume":"68","author":"H-H Lu","year":"1994","unstructured":"Lu H-H, Yang C-F, Murdin AD, Klein MH, Harber JJ, Kew OM et al (1994) Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro. J Virol 68(11):7507\u20137515","journal-title":"J Virol"},{"key":"2214_CR40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.antiviral.2014.05.005","volume":"108","author":"RD Puligedda","year":"2014","unstructured":"Puligedda RD, Kouiavskaia D, Adekar SP, Sharma R, Kattala CD, Rezapkin G et al (2014) Human monoclonal antibodies that neutralize vaccine and wild-type poliovirus strains. Antiviral Res 108:36\u201343","journal-title":"Antiviral Res"},{"issue":"1","key":"2214_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41052-9","volume":"14","author":"AJ Charnesky","year":"2023","unstructured":"Charnesky AJ, Faust JE, Lee H, Puligedda RD, Goetschius DJ, DiNunno NM et al (2023) A human monoclonal antibody binds within the poliovirus receptor-binding site to neutralize all three serotypes. Nat Commun 14(1):6335","journal-title":"Nat Commun"},{"issue":"1","key":"2214_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28215","volume":"95","author":"Q Fan","year":"2023","unstructured":"Fan Q, Ma J, Li X, Jorba J, Yuan F, Zhu H et al (2023) Molecular evolution and antigenic drift of type 3 iVDPVs excreted from a patient with immunodeficiency in Ningxia, China. J Med Virol 95(1):e28215","journal-title":"J Med Virol"},{"issue":"10","key":"2214_CR43","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.vaccine.2015.01.018","volume":"33","author":"J Guo","year":"2015","unstructured":"Guo J, Bolivar-Wagers S, Srinivas N, Holubar M, Maldonado Y (2015) Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication. Vaccine 33(10):1235\u20131242","journal-title":"Vaccine"},{"issue":"13","key":"2214_CR44","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.vaccine.2018.02.059","volume":"36","author":"M Shaghaghi","year":"2018","unstructured":"Shaghaghi M, Soleyman-Jahi S, Abolhassani H, Yazdani R, Azizi G, Rezaei N et al (2018) New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data. Vaccine 36(13):1711\u20131719","journal-title":"Vaccine"},{"issue":"6","key":"2214_CR45","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1586\/14760584.2016.1140041","volume":"15","author":"J Garon","year":"2016","unstructured":"Garon J, Seib K, Orenstein WA, Ramirez Gonzalez A, Chang Blanc D, Zaffran M et al (2016) Polio endgame: the global switch from tOPV to bOPV. Expert Rev Vaccines 15(6):693\u2013708","journal-title":"Expert Rev Vaccines"}],"container-title":["Virus Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-026-02214-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11262-026-02214-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-026-02214-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T07:26:37Z","timestamp":1775287597000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11262-026-02214-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2214"],"URL":"https:\/\/doi.org\/10.1007\/s11262-026-02214-1","relation":{},"ISSN":["0920-8569","1572-994X"],"issn-type":[{"value":"0920-8569","type":"print"},{"value":"1572-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Samples were routinely collected in the scope of AFP surveillance program for poliovirus detection, as part of the WHO and Ministry of Health and Medical Education. Therefore, this study did not require an ethical approval to conduct the research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This research did not involve human participants and\/or animals out of poliovirus surveillance.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal rights"}}]}}